The (cost)-effectiveness of an early admission to and assessment in the nursing home for stroke patients

The (cost)-effectiveness of an early admission to and assessment in the nursing home for stroke patients: a multicentre non-randomised comparative trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN58135104

Enrollment

222

Registered

2010-01-04

Start date

2009-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Circulatory System Stroke, not specified as haemorrhage or infarction

Interventions

The intervention consists of the execution of a redesigned care pathway for stroke patients admitted to the Maastricht University Medical Centre. Every patient with a suspected stroke will be analysed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Acute stroke patients' admitted to one of the hospitals participating in the trial 2. Aged 18 years or older 3. Either sex 4. Willingness to participate

Exclusion criteria

Exclusion criteria: 1. A previous diagnosis of dementia 2. Unable to communicate in Dutch

Design outcomes

Primary

Measure	Time frame
Total direct and indirect costs per patient during the first 6 months post-stroke. The economic evaluation will involve a combination of a cost-effectiveness analysis and a cost-utility analysis. The primary outcome measure of the cost-effectiveness analysis will be the Stroke-Adapted 30-Item Version of the Sickness Impact Profile (SASIP-30). Within the cost-utility analysis, outcomes will be measured by means of standard Dutch version of the Euroqol (EQ-5D). This is a self-administered questionnaire, which will be completed together with a cost questionnaire in which the resource utilisation is recorded. Measurements are taken at baseline and after 3 and 6 months post-stroke.	—

Measure

Time frame

Total direct and indirect costs per patient during the first 6 months post-stroke. The economic evaluation will involve a combination of a cost-effectiveness analysis and a cost-utility analysis. The primary outcome measure of the cost-effectiveness analysis will be the Stroke-Adapted 30-Item Version of the Sickness Impact Profile (SASIP-30). Within the cost-utility analysis, outcomes will be measured by means of standard Dutch version of the Euroqol (EQ-5D). This is a self-administered questionnaire, which will be completed together with a cost questionnaire in which the resource utilisation is recorded. Measurements are taken at baseline and after 3 and 6 months post-stroke.

—

Secondary

Measure	Time frame
1. Instrumental activities of daily living measured by means of the Frenchay Activity Index, assessed at baseline and at 3 and 6 months 2. Handicap measured by means of the Modified Rankin Score, assessed at baseline and at 3 and 6 months 3. Cognitive functioning measured by means of Mini Mental State Examination, Apraxia Test and Star Cancellation Test, assessed at baseline and at 3 and 6 months 4. Anxiety and depression measured by the Hospital Anxiety and Depression Scale, assessed at baseline and at 3 and 6 months 5. Patients' satisfaction with stroke care measured by means of the Satisfaction with Stroke Care Questionnaire, assessed at baseline and at 3 and 6 months 6. Strain on caregivers measured by the Caregivers Strain Index, assessed at baseline and at 3 and 6 months 7. Medical complications occurring within 3 months after stroke. The following diagnoses are regarded as medical complications: a new stroke, epileptic seizures, pneumonia, urinary tract infections, fractures, bedsores, myocardial infarctions, heart failure and atrial fibrillation. The data on the medical complications will be collected from the patients' file. Background variables: The following will also be measured, which are considered to be predictors, confounders or effect modifiers. The following personal characteristics are assessed: 8. Age 9. Sex 10. Socio-economic status 11. Risk factors 12. Co-morbidity 13. Stroke location 14. Stroke severity measured by the National Institute of Health Stroke Scale All background variables are measured at baseline.	—

Measure

Time frame

1. Instrumental activities of daily living measured by means of the Frenchay Activity Index, assessed at baseline and at 3 and 6 months 2. Handicap measured by means of the Modified Rankin Score, assessed at baseline and at 3 and 6 months 3. Cognitive functioning measured by means of Mini Mental State Examination, Apraxia Test and Star Cancellation Test, assessed at baseline and at 3 and 6 months 4. Anxiety and depression measured by the Hospital Anxiety and Depression Scale, assessed at baseline and at 3 and 6 months 5. Patients' satisfaction with stroke care measured by means of the Satisfaction with Stroke Care Questionnaire, assessed at baseline and at 3 and 6 months 6. Strain on caregivers measured by the Caregivers Strain Index, assessed at baseline and at 3 and 6 months 7. Medical complications occurring within 3 months after stroke. The following diagnoses are regarded as medical complications: a new stroke, epileptic seizures, pneumonia, urinary tract infections, fractures, bedsores, myocardial infarctions, heart failure and atrial fibrillation. The data on the medical complications will be collected from the patients' file. Background variables: The following will also be measured, which are considered to be predictors, confounders or effect modifiers. The following personal characteristics are assessed: 8. Age 9. Sex 10. Socio-economic status 11. Risk factors 12. Co-morbidity 13. Stroke location 14. Stroke severity measured by the National Institute of Health Stroke Scale All background variables are measured at baseline.

—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 31, 2026